Details for New Drug Application (NDA): 205604
✉ Email this page to a colleague
The generic ingredient in AMIKACIN SULFATE is amikacin sulfate. There are fifteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the amikacin sulfate profile page.
Summary for 205604
Tradename: | AMIKACIN SULFATE |
Applicant: | Fresenius Kabi Usa |
Ingredient: | amikacin sulfate |
Patents: | 0 |
Suppliers and Packaging for NDA: 205604
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
AMIKACIN SULFATE | amikacin sulfate | INJECTABLE;INJECTION | 205604 | ANDA | Fresenius Kabi USA, LLC | 63323-815 | 63323-815-02 | 10 VIAL, SINGLE-DOSE in 1 CARTON (63323-815-02) / 2 mL in 1 VIAL, SINGLE-DOSE (63323-815-21) |
AMIKACIN SULFATE | amikacin sulfate | INJECTABLE;INJECTION | 205604 | ANDA | Fresenius Kabi USA, LLC | 63323-815 | 63323-815-04 | 10 VIAL, SINGLE-DOSE in 1 CARTON (63323-815-04) / 4 mL in 1 VIAL, SINGLE-DOSE (63323-815-22) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 250MG BASE/ML | ||||
Approval Date: | Dec 9, 2015 | TE: | AP | RLD: | No |
Complete Access Available with Subscription